annual EBITDA:
-$101.45M-$53.63M(-112.16%)Summary
- As of today (May 29, 2025), DNTH annual EBITDA is -$101.45 million, with the most recent change of -$53.63 million (-112.16%) on December 31, 2024.
- During the last 3 years, DNTH annual EBITDA has fallen by -$88.37 million (-675.27%).
- DNTH annual EBITDA is now -675.27% below its all-time high of -$13.09 million, reached on December 31, 2021.
Performance
DNTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$33.04M-$1.21M(-3.79%)Summary
- As of today (May 29, 2025), DNTH quarterly EBITDA is -$33.04 million, with the most recent change of -$1.21 million (-3.79%) on March 31, 2025.
- Over the past year, DNTH quarterly EBITDA has dropped by -$15.31 million (-86.30%).
- DNTH quarterly EBITDA is now -334.68% below its all-time high of -$7.60 million, reached on March 1, 2023.
Performance
DNTH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$116.76M-$15.31M(-15.09%)Summary
- As of today (May 29, 2025), DNTH TTM EBITDA is -$116.76 million, with the most recent change of -$15.31 million (-15.09%) on March 31, 2025.
- Over the past year, DNTH TTM EBITDA has dropped by -$58.80 million (-101.47%).
- DNTH TTM EBITDA is now -1314.57% below its all-time high of -$8.25 million, reached on September 30, 2022.
Performance
DNTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNTH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -112.2% | -86.3% | -101.5% |
| 3 y3 years | -675.3% | -300.3% | -1314.6% |
| 5 y5 years | -675.3% | -300.3% | -1314.6% |
DNTH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -675.3% | at low | -334.7% | at low | -1314.6% | at low |
| 5 y | 5-year | -675.3% | at low | -334.7% | at low | -1314.6% | at low |
| alltime | all time | -675.3% | at low | -334.7% | at low | -1314.6% | at low |
DNTH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$33.04M(+3.8%) | -$116.76M(+15.1%) |
| Dec 2024 | -$101.45M(+112.2%) | -$31.84M(+6.9%) | -$101.45M(+23.0%) |
| Sep 2024 | - | -$29.78M(+34.8%) | -$82.47M(+20.6%) |
| Jun 2024 | - | -$22.09M(+24.6%) | -$68.36M(+17.9%) |
| Mar 2024 | - | -$17.74M(+38.0%) | -$57.95M(+21.2%) |
| Dec 2023 | -$47.82M | -$12.85M(-18.0%) | -$47.82M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$15.67M(+34.0%) | -$45.61M(+19.4%) |
| Jun 2023 | - | -$11.69M(+53.8%) | -$38.19M(+44.1%) |
| Mar 2023 | - | -$7.60M(-28.6%) | -$26.50M(+40.2%) |
| Dec 2022 | -$29.56M(+125.9%) | -$10.64M(+29.0%) | -$18.90M(+129.0%) |
| Sep 2022 | - | -$8.25M | -$8.25M |
| Dec 2021 | -$13.09M | - | - |
FAQ
- What is Dianthus Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual EBITDA year-on-year change?
- What is Dianthus Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly EBITDA year-on-year change?
- What is Dianthus Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Dianthus Therapeutics?
- What is Dianthus Therapeutics TTM EBITDA year-on-year change?
What is Dianthus Therapeutics annual EBITDA?
The current annual EBITDA of DNTH is -$101.45M
What is the all time high annual EBITDA for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual EBITDA is -$13.09M
What is Dianthus Therapeutics annual EBITDA year-on-year change?
Over the past year, DNTH annual EBITDA has changed by -$53.63M (-112.16%)
What is Dianthus Therapeutics quarterly EBITDA?
The current quarterly EBITDA of DNTH is -$33.04M
What is the all time high quarterly EBITDA for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly EBITDA is -$7.60M
What is Dianthus Therapeutics quarterly EBITDA year-on-year change?
Over the past year, DNTH quarterly EBITDA has changed by -$15.31M (-86.30%)
What is Dianthus Therapeutics TTM EBITDA?
The current TTM EBITDA of DNTH is -$116.76M
What is the all time high TTM EBITDA for Dianthus Therapeutics?
Dianthus Therapeutics all-time high TTM EBITDA is -$8.25M
What is Dianthus Therapeutics TTM EBITDA year-on-year change?
Over the past year, DNTH TTM EBITDA has changed by -$58.80M (-101.47%)